NAD+ Pen – 1000mg
The NAD+ Pen contains 1000 mg of Nicotinamide Adenine Dinucleotide (NAD+) in a convenient 2.6 mL pre-filled peptide pen. With 240 precision clicks and a multi-dose format, it provides a convenient way to conduct research involving NAD+ and pathways associated with cellular energy, mitochondrial function, metabolic health and healthy ageing.
Each pen is supplied with 6 sterile needles.
Key Features
- 1000 mg NAD+ per pen
- 2.6 mL pre-filled pen
- 240 precision clicks
- Approximately 4.167 mg NAD+ per click
- 12 clicks ≈ 50 mg
- 18 clicks ≈ 75 mg
- 24 clicks ≈ 100 mg
- Supplied with 6 sterile needles
- Research interest in cellular energy and mitochondrial pathways
- Convenient multi-dose format
- Precision MSSPT peptide pen technology
About NAD+
Nicotinamide Adenine Dinucleotide (NAD+) is a naturally occurring coenzyme found throughout living cells and plays a central role in energy metabolism and cellular redox processes.
NAD+ is involved in several important enzyme systems, including sirtuins, PARPs and CD38/CD157. Research into NAD+ biology has explored its relationship with mitochondrial function, ATP production, DNA repair, cellular signalling, oxidative stress and metabolic processes.
NAD+ research has become particularly relevant to studies of cellular ageing, energy metabolism, recovery and mitochondrial health.
Research Areas
NAD+ is being investigated in relation to:
- Cellular energy production
- Mitochondrial function
- NAD+/NADH metabolism
- Metabolic pathways
- Cellular repair and resilience
- Oxidative stress pathways
- Healthy ageing research
These are areas of research interest and should not be interpreted as established medical benefits or treatment claims.
Research Dosage Protocol
The following information is the manufacturer-supplied research protocol and is provided for research reference only. It is not a recommendation or instruction for human use.
Standard research protocol:
- 50 mg per administration
- Approximately 12 clicks
Higher research protocol:
- 75 mg: approximately 18 clicks
- 100 mg: approximately 24 clicks
Frequency described in the supplied protocol:
- Loading phase: 50 mg daily or 5–7 times per week for the first 1–2 weeks
- Maintenance phase: 50 mg approximately 2–3 times per week or every other day
- Research cycle: 4–12 weeks, with the supplied protocol describing periods of approximately 30–90 days followed by a 4-week break
Click conversion: approximately 4.167 mg NAD+ per click.
Precision Peptide Pen Technology
The NAD+ Pen incorporates MSSPT (Molecular Stabilisation and Storage Protection Technology), designed to support formulation stability against environmental factors such as light, oxygen, moisture and temperature fluctuations.
The pre-filled format provides convenient click-based measurement without the need for conventional reconstitution.
Storage & Handling
- Store according to the manufacturer’s recommended storage conditions.
- Refrigerate where specified and never freeze.
- If stored outside refrigeration, keep in a cool, dry environment within the recommended temperature range.
- Keep the pen capped and protected from direct light and excessive heat.
- Keep out of reach of children.
- Do not use if the solution is cloudy, discoloured or contains visible particles.
- Discard expired or visibly compromised product appropriately.
Our guide NAD+ vs NMN: the molecule and its precursor explains how the two relate, what the human research shows, and how our vial and pens compare on price.
Research & Safety Information
NAD+ is supplied by Lekker Peptides for research purposes only. The information provided is intended for educational and research purposes and should not be interpreted as medical advice or as evidence that NAD+ treats or prevents any medical condition.
This product is not intended to diagnose, treat, cure or prevent any disease. Statements have not been evaluated or approved by SAHPRA, the FDA or other regulatory authorities for the uses described above.
Research involving NAD+ should be conducted with appropriate professional oversight, particularly where underlying medical conditions or other medications may be relevant.
For research use only. Not for human consumption.




